From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Results: PYC

Search articles by EPIC code
EPIC PYC
views

Physiomics – “signs of returning to normality”, so why the share price fall?...

Physiomics (PYC) has updated including “we already see that clinical trials and patient recruitment are showing signs of returning to normality” and “the company's cash position remains strong, and it is estimated that on 30 June 2021 its net asset position will be c.£1.1m, the majority of which is cash”. Why then have the shares currently responded to 5.95p, more than 7% lower?...

EPIC PYC
views

Physiomics – what goes up?

The reality is the odds are stacked against you in the Aim market particularly if your relative experience of the small cap market is one based on theory or conjecture.  That brings me to Physiomics (PYC) – shares in which gained 113% yesterday.

EPIC PYC
views

Get Physical With Physiomics

 

Physiomics is another of the more obscure minnows showing up on the technical radar at the moment, and even though the current share price which is in the middle of the past one-year range may not immediately appear to be compelling as a buying opportunity, from a technical perspective there is plenty of excitement to be had.

  • By
  • 2013-06-21 04:16:39
Page 1 of 1 (10 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments